Intrinsic Value

The intrinsic value of Tempus AI Inc (F3M) under the Base Case is 60.3 EUR per share. Compared with the current market price of 59.77 EUR, the stock appears Undervalued by 1% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

F3M Intrinsic Value
€60.3
Undervaluation 1%
Intrinsic Value
Price €59.77
T

We don’t have enough historical valuation data to make this comparison.

Monitor F3M
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €48.24
Get notified when the price drops into your buy zone
Intrinsic Value €60.3
Current Price €59.77
Margin of Safety 20% €48.24
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to F3M

Fundamental Analysis

What Tempus AI Does

Life Sciences Tools & Services Health Care

Tempus AI builds software and diagnostic tools that help doctors and researchers use medical data, especially in cancer care and other complex diseases. It collects and analyzes clinical records, imaging, and molecular test results to help match patients with the right tests, treatments, and trial options. Its products are used mainly by hospitals, oncologists, life-science companies, and research groups that need better decision support from large amounts of health data.

Headquarters
United States of America US
Employees
3 800
IPO date
May 30, 2025
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Tempus AI Inc

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

TEM Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one F3M stock?

The intrinsic value for Tempus AI Inc (F3M) under the Base Case is 60.3 EUR.

Is F3M stock undervalued or overvalued?

Compared with the current market price of 59.77 EUR, the stock appears Undervalued by 1% .

Back to Top